Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

How immediate and significant is the outcome of training on diversified diets, hygiene and food safety? An effort to mitigate child undernutrition in rural Malawi.

Seetha A, Tsusaka TW, Munthali TW, Musukwa M, Mwangwela A, Kalumikiza Z, Manani T, Kachulu L, Kumwenda N, Musoke M, Okori P.

Public Health Nutr. 2018 Apr;21(6):1156-1166. doi: 10.1017/S1368980017003652. Epub 2018 Jan 17.

2.

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.

Palumbo PJ, Wilson EA, Piwowar-Manning E, McCauley M, Gamble T, Kumwenda N, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim JG, Hosseinipour MC, Melo MG, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Chen YQ, Cohen MS, Eshleman SH, Fogel JM.

PLoS One. 2017 May 8;12(5):e0177281. doi: 10.1371/journal.pone.0177281. eCollection 2017.

3.

Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057.

Osorio LE, Boechat MI, Mirochnick M, Kumwenda N, Kreitchmann R, Emel L, Pinto J, Joao E, Santos B, Swenson M, George K, Sato P, Mofenson L, Nielsen-Saines K; HIV Prevention Trials Network (HPTN) 057 Protocol Team.

Pediatr Infect Dis J. 2017 Feb;36(2):184-188. doi: 10.1097/INF.0000000000001386.

4.

Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.

Schwartz SR, Kumwenda N, Kumwenda J, Chen S, Mofenson LM, Taylor AW, Fowler MG, Taha TE.

Matern Child Health J. 2016 Mar;20(3):542-9. doi: 10.1007/s10995-015-1852-5.

5.

Evaluation of postpartum HIV superinfection and mother-to-child transmission.

Redd AD, Wendel SK, Longosz AF, Fogel JM, Dadabhai S, Kumwenda N, Sun J, Walker MP, Bruno D, Martens C, Eshleman SH, Porcella SF, Quinn TC, Taha TE.

AIDS. 2015 Jul 31;29(12):1567-73. doi: 10.1097/QAD.0000000000000740.

6.

Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi.

Taha TE, Rusie LK, Labrique A, Nyirenda M, Soko D, Kamanga M, Kumwenda J, Farazadegan H, Nelson K, Kumwenda N.

Emerg Infect Dis. 2015 Jul;21(7):1174-82. doi: 10.3201/eid2107.141748.

7.

Training for health services and systems research in Sub-Saharan Africa--a case study at four East and Southern African universities.

Guwatudde D, Bwanga F, Dudley L, Chola L, Leyna GH, Mmbaga EJ, Kumwenda N, Protsiv M, Atkins S, Zwarenstein M, Obua C, Tumwine JK.

Hum Resour Health. 2013 Dec 23;11:68. doi: 10.1186/1478-4491-11-68.

8.

Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.

Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison CS, Salata RA, Chipato T, Celum C, Kahle EM, Taha TE, Kumwenda NI, Karim QA, Naranbhai V, Lingappa JR, Sweat MD, Coates T, Eshleman SH.

PLoS One. 2013 Nov 13;8(11):e78818. doi: 10.1371/journal.pone.0078818. eCollection 2013.

9.

Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035).

Gorbach PM, Kelly CW, Borgerding JA, Ramjee G, Tembo T, Kumwenda N, Musara P, Roberts S, Maslankowski L.

AIDS Behav. 2014 May;18(5):855-61. doi: 10.1007/s10461-013-0651-5.

10.

Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life.

Mirochnick M, Taha T, Kreitchmann R, Nielsen-Saines K, Kumwenda N, Joao E, Pinto J, Santos B, Parsons T, Kearney B, Emel L, Herron C, Richardson P, Hudelson SE, Eshleman SH, George K, Fowler MG, Sato P, Mofenson L; HPTN 057 Protocol Team.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):33-41. doi: 10.1097/QAI.0b013e3182a921eb.

11.

Antibody maturation and viral diversification in HIV-infected women.

James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH.

PLoS One. 2013;8(2):e57350. doi: 10.1371/journal.pone.0057350. Epub 2013 Feb 27.

12.

Vitamin D levels in Malawian infants from birth to 24 months.

Amukele TK, Soko D, Katundu P, Kamanga M, Sun J, Kumwenda NI, Taha TE.

Arch Dis Child. 2013 Mar;98(3):180-3. doi: 10.1136/archdischild-2012-302377. Epub 2012 Dec 7.

PMID:
23220204
13.

Distribution of haematological and chemical pathology values among infants in Malawi and Uganda.

Kumwenda NI, Khonje T, Mipando L, Nkanaunena K, Katundu P, Lubega I, Elbireer A, Bolton S, Bagenda D, Mubiru M, Fowler MG, Taha TE.

Paediatr Int Child Health. 2012;32(4):213-27. doi: 10.1179/2046905512Y.0000000034.

14.

Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.

Hudgens MG, Taha TE, Omer SB, Jamieson DJ, Lee H, Mofenson LM, Chasela C, Kourtis AP, Kumwenda N, Ruff A, Bedri A, Jackson JB, Musoke P, Bollinger RC, Gupte N, Thigpen MC, Taylor A, van der Horst C.

Clin Infect Dis. 2013 Jan;56(1):131-9. doi: 10.1093/cid/cis808. Epub 2012 Sep 20.

15.

Child mortality levels and trends by HIV status in Blantyre, Malawi: 1989-2009.

Taha TE, Dadabhai SS, Sun J, Rahman MH, Kumwenda J, Kumwenda N.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):226-34.

16.

Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.

Fogel JM, Taha TE, Sun J, Hoover DR, Parsons TL, Kumwenda JJ, Mofenson LM, Fowler MG, Hendrix CW, Kumwenda NI, Eshleman SH, Mirochnick M.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):462-5.

17.

Trends in birth weight and gestational age for infants born to HIV-infected, antiretroviral treatment-naive women in Malawi.

Taha TE, Dadabhai SS, Rahman MH, Sun J, Kumwenda J, Kumwenda NI.

Pediatr Infect Dis J. 2012 May;31(5):481-6. doi: 10.1097/INF.0b013e31824d9bd9.

18.

Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi.

Taha TE, Hoover DR, Chen S, Kumwenda NI, Mipando L, Nkanaunena K, Thigpen MC, Taylor A, Fowler MG, Mofenson LM.

Clin Infect Dis. 2011 Aug;53(4):388-95. doi: 10.1093/cid/cir413.

19.

Coverage of highly active antiretroviral therapy among postpartum women in Malawi.

Kumwenda J, Matchere F, Mataya R, Chen S, Mipando L, Li Q, Kumwenda NI, Taha TE.

Int J STD AIDS. 2011 Jul;22(7):368-72. doi: 10.1258/ijsa.2011.010359.

PMID:
21729953
20.

Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.

Fogel J, Hoover DR, Sun J, Mofenson LM, Fowler MG, Taylor AW, Kumwenda N, Taha TE, Eshleman SH.

AIDS. 2011 Apr 24;25(7):911-7. doi: 10.1097/QAD.0b013e328344fedc.

21.

Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.

Fogel J, Li Q, Taha TE, Hoover DR, Kumwenda NI, Mofenson LM, Kumwenda JJ, Fowler MG, Thigpen MC, Eshleman SH.

Clin Infect Dis. 2011 Apr 15;52(8):1069-76. doi: 10.1093/cid/cir008.

22.

Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial.

Taha TE, Li Q, Hoover DR, Mipando L, Nkanaunena K, Thigpen MC, Taylor A, Kumwenda J, Fowler MG, Mofenson LM, Kumwenda NI.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):319-25. doi: 10.1097/QAI.0b013e318217877a.

PMID:
21423025
23.

Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants.

Lubega IR, Fowler MG, Musoke PM, Elbireer A, Bagenda D, Kafulafula G, Ko J, Mipando L, Mubiru M, Kumwenda N, Taha T, Jackson JB, Guay L.

J Acquir Immune Defic Syndr. 2010 Sep;55(1):58-64. doi: 10.1097/QAI.0b013e3181db059d.

24.

Factors related to attrition in a cohort study of HIV in Malawi.

Obasanjo OO, Kumwenda N.

East Afr Med J. 2009 Aug;86(8):399-408.

PMID:
20575314
25.

The effect of human immunodeficiency virus and breastfeeding on the nutritional status of African children.

Taha T, Nour S, Li Q, Kumwenda N, Kafulafula G, Nkhoma C, Broadhead R.

Pediatr Infect Dis J. 2010 Jun;29(6):514-8. doi: 10.1097/INF.0b013e3181cda531.

PMID:
20054287
26.

Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.

Lidström J, Li Q, Hoover DR, Kafulafula G, Mofenson LM, Fowler MG, Thigpen MC, Kumwenda N, Taha TE, Eshleman SH.

AIDS. 2010 Jan 28;24(3):381-6. doi: 10.1097/QAD.0b013e3283352ef1.

27.

Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi.

Kafulafula G, Hoover DR, Taha TE, Thigpen M, Li Q, Fowler MG, Kumwenda NI, Nkanaunena K, Mipando L, Mofenson LM.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):6-13. doi: 10.1097/QAI.0b013e3181bd5a47.

PMID:
19844183
28.

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.

J Infect Dis. 2009 Nov 15;200(10):1490-7. doi: 10.1086/644598.

PMID:
19832114
29.

Resumption of sexual activity and regular menses after childbirth among women infected with HIV in Malawi.

Makanani B, Kumwenda J, Kumwenda N, Chen S, Tsui A, Taha TE.

Int J Gynaecol Obstet. 2010 Jan;108(1):26-30. doi: 10.1016/j.ijgo.2009.08.014.

PMID:
19782980
30.

Fertility intentions of HIV-1 infected and uninfected women in Malawi: a longitudinal study.

Taulo F, Berry M, Tsui A, Makanani B, Kafulafula G, Li Q, Nkhoma C, Kumwenda JJ, Kumwenda N, Taha TE.

AIDS Behav. 2009 Jun;13 Suppl 1:20-7. doi: 10.1007/s10461-009-9547-9. Epub 2009 Mar 24.

PMID:
19308718
31.

The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newborns.

Biggar RJ, Lee TH, Wen L, Broadhead R, Kumwenda N, Taha TE, Busch MP.

AIDS. 2008 Nov 12;22(17):2251-6. doi: 10.1097/QAD.0b013e328314e36b.

32.

The role of men in women's acceptance of an intravaginal gel in a randomized clinical trial in Blantyre, Malawi: a qualitative and quantitative analysis.

Salter ML, Go VF, Celentano DD, Diener-West M, Nkhoma CM, Kumwenda N, Taha TE.

AIDS Care. 2008 Aug;20(7):853-62. doi: 10.1080/09540120701742300.

PMID:
18608053
33.

Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.

Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Mipando L, Nkanaunena K, Mebrahtu T, Bulterys M, Fowler MG, Taha TE.

N Engl J Med. 2008 Jul 10;359(2):119-29. doi: 10.1056/NEJMoa0801941. Epub 2008 Jun 4. Erratum in: N Engl J Med. 2018 Jun 13;:null.

34.

HIV-1 incidence among women of reproductive age in Malawi.

Kumwenda NI, Kumwenda J, Kafulafula G, Makanani B, Taulo F, Nkhoma C, Li Q, Taha TE.

Int J STD AIDS. 2008 May;19(5):339-41. doi: 10.1258/ijsa.2007.007165.

PMID:
18482966
35.

Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi.

Kumwenda JJ, Makanani B, Taulo F, Nkhoma C, Kafulafula G, Li Q, Kumwenda N, Taha TE.

Clin Infect Dis. 2008 Jun 15;46(12):1913-20. doi: 10.1086/588478.

PMID:
18462100
36.

Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants.

Church JD, Towler WI, Hoover DR, Hudelson SE, Kumwenda N, Taha TE, Eshleman JR, Eshleman SH.

AIDS Res Hum Retroviruses. 2008 Apr;24(4):595-605. doi: 10.1089/aid.2007.0224.

PMID:
18370589
37.

HIV seroreversion time in HIV-1-uninfected children born to HIV-1-infected mothers in Malawi.

Gulia J, Kumwenda N, Li Q, Taha TE.

J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):332-7.

PMID:
17786126
38.

Micronutrient supplements and mortality of HIV-infected adults with pulmonary TB: a controlled clinical trial.

Semba RD, Kumwenda J, Zijlstra E, Ricks MO, van Lettow M, Whalen C, Clark TD, Jorgensen L, Kohler J, Kumwenda N, Taha TE, Harries AD.

Int J Tuberc Lung Dis. 2007 Aug;11(8):854-9.

PMID:
17705950
39.

HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.

Church JD, Hudelson SE, Guay LA, Chen S, Hoover DR, Parkin N, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Eshleman SH.

AIDS Res Hum Retroviruses. 2007 Jun;23(6):764-8.

PMID:
17604538
40.

Late postnatal transmission of HIV-1 and associated factors.

Taha TE, Hoover DR, Kumwenda NI, Fiscus SA, Kafulafula G, Nkhoma C, Chen S, Piwowar E, Broadhead RL, Jackson JB, Miotti PG.

J Infect Dis. 2007 Jul 1;196(1):10-4. Epub 2007 May 24.

PMID:
17538877
41.

Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial.

Taha TE, Kumwenda NI, Kafulafula G, Makanani B, Nkhoma C, Chen S, Tsui A, Hoover DR.

PLoS Clin Trials. 2007 Feb 23;2(2):e10.

42.

Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.

Church JD, Jones D, Flys T, Hoover D, Marlowe N, Chen S, Shi C, Eshleman JR, Guay LA, Jackson JB, Kumwenda N, Taha TE, Eshleman SH.

J Mol Diagn. 2006 Sep;8(4):430-2; quiz 527.

43.

The impact of breastfeeding on the health of HIV-positive mothers and their children in sub-Saharan Africa.

Taha TE, Kumwenda NI, Hoover DR, Kafulafula G, Fiscus SA, Nkhoma C, Chen S, Broadhead RL.

Bull World Health Organ. 2006 Jul;84(7):546-54.

44.

Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.

Eshleman SH, Church JD, Chen S, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Hoover DR.

J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):518-21. No abstract available.

PMID:
16810119
45.

HIV incidence among women of reproductive age in Malawi and Zimbabwe.

Kumwenda N, Hoffman I, Chirenje M, Kelly C, Coletti A, Ristow A, Martinson F, Brown J, Chilongozi D, Richardson B, Rosenberg Z, Padian N, Taha T.

Sex Transm Dis. 2006 Nov;33(11):646-51.

PMID:
16773032
46.

Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.

Flys TS, Chen S, Jones DC, Hoover DR, Church JD, Fiscus SA, Mwatha A, Guay LA, Mmiro F, Musoke P, Kumwenda N, Taha TE, Jackson JB, Eshleman SH.

J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):610-3.

PMID:
16773030
47.

Association between the replication capacity and mother-to-child transmission of HIV-1, in antiretroviral drug-naive Malawian women.

Eshleman SH, Lie Y, Hoover DR, Chen S, Hudelson SE, Fiscus SA, Petropoulos CJ, Kumwenda N, Parkin N, Taha TE.

J Infect Dis. 2006 Jun 1;193(11):1512-5. Epub 2006 Apr 20.

PMID:
16652278
48.

Higher in utero and perinatal HIV infection risk in girls than boys.

Biggar RJ, Taha TE, Hoover DR, Yellin F, Kumwenda N, Broadhead R.

J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):509-13.

PMID:
16652061
49.

Status of carotenoids, vitamin A, and vitamin E in the mother-infant dyad and anthropometric status of infants in Malawi.

Dancheck B, Nussenblatt V, Kumwenda N, Lema V, Neville MC, Broadhead R, Taha TE, Ricks MO, Semba RD.

J Health Popul Nutr. 2005 Dec;23(4):343-50.

PMID:
16599105
50.

Effect of antibiotic treatment of subclinical mastitis on human immunodeficiency virus type 1 RNA in human milk.

Nussenblatt V, Kumwenda N, Lema V, Quinn T, Neville MC, Broadhead R, Taha TE, Semba RD.

J Trop Pediatr. 2006 Oct;52(5):311-5. Epub 2006 Apr 4.

PMID:
16595526

Supplemental Content

Loading ...
Support Center